相关实验视频
Updated: Jul 9, 2026

12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
改善2型糖尿病在风险人群中的检测 - 通过点毛细血管HbA1c测试和静脉HbA1c测试比较活跃机会性查的有效性:一个集群随机对照试验
Linda Chan1,2,3, Esther Yee Tak Yu4, Eric Yuk Fai Wan5,6,7,8
1Department of Family Medicine and Primary Care, Ap Lei Chau Clinic, The University of Hong Kong, 3/F, 161 Main Street, Ap Lei Chau, Hong Kong SAR, China. lmjchan@hku.hk.
BMC medicine
|April 1, 2025
概括
与传统的静脉HbA1c (vHbA1c) 测试相比,点诊所毛细血管HbA1c (POC-cHbA1c) 测试显著提高了2型糖尿病检测率和患者吸收率. 这一战略显示了有效的初级保健查的前景.
科学领域:
- 内分泌学 在内分泌学.
- 主要护理医学 医疗保健
- 临床诊断 临床诊断 临床诊断
背景情况:
- 未被诊断的2型糖尿病是香港的一个重大问题,导致糖尿病相关并发症的增加.
- 照顾点毛细血管HbA1c (POC-cHbA1c) 为糖尿病查提供了方便和及时的替代静脉HbA1c (vHbA1c).
- 需要随机试验来比较POC-cHbA1c与初级保健机构的vHbA1c.
研究的目的:
- 为了比较使用POC-cHbA1c的2步活跃机会性查策略与使用vHbA1c的常规实践在检测2型糖尿病中的有效性.
- 为了评估POC-cHbA1c和vHbA1c测试之间的2型糖尿病检测率的差异.
- 为了比较POC-cHbA1c与vHbA1c测试在高危初级保健患者中的吸收率.
主要方法:
- 一个集群随机对照试验于2022年6月至2024年1月在8家一般外科诊所进行.
- 确定了852名风险患者,并接受了POC-cHbA1c (干预) 或vHbA1c (控制) 测试.
- 使用多级逻辑回归分析来评估干预对吸收率的影响,并根据患者特征和诊所集群进行调整.
主要成果:
- 与vHbA1c (37.5%) 相比,POC-cHbA1c的吸收率显著更高 (76.0%).
- 在POC-cHbA1c.c.检测到的2型糖尿病 (4.2%对1.4%) 和糖尿病前期 (11.8%对6.9%) 的比例更高.
- 在检测2型糖尿病/糖尿病前期组合时,POC-cHbA1c更有效 (OR=1.99).
结论:
- 在初级保健中,POC-cHbA1c测试与更高的吸收率和更好的2型糖尿病和糖尿病前期的检测有关.
- 这一战略显示了在初级保健机构有效查2型糖尿病的巨大潜力.
- 这些发现支持将POC-cHbA1c纳入机会性查协议.
相关概念视频
Carbohydrate Metabolism
10.6K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
10.6K
Diabetes Mellitus: Overview and Type I Subtype
2.3K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.3K
Diabetes Mellitus: Type 2 and Gestational
2.1K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.1K
Diabetes: Symptoms, Diagnosis, and Complications
488
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
488
Diabetes: Management and Pharmacotherapy
214
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
214

